Links to 18 New PubMed Abstracts

[Guest guest]

30. THOMPSON AJ, PJ, Singh A, Ge D, et al.

Genome-wide association study of interferon-related cytopenia in chronic

hepatitis C patients.

J Hepatol. 2011.

http://amedeo.com/p2.php?id=21703177 & s=hep & pm=3e5d26a0f9107d3

ABSTRACT available

31. HUANG CF, Huang JF, Yang JF, Hsieh MY, et al.

Interleukin-28B genetic variants in identification of hepatitis C virus genotype

1 patients responding to 24 weeks peginterferon/ribavirin.

J Hepatol. 2011.

http://amedeo.com/p2.php?id=21703176 & s=hep & pm=3e5d26a0f9107d3

ABSTRACT available

32. DELANG L, Vliegen I, Leyssen P, Neyts J, et al.

In vitro selection and characterization of HCV replicons resistant to multiple

non-nucleoside polymerase inhibitors.

J Hepatol. 2011.

http://amedeo.com/p2.php?id=21703175 & s=hep & pm=3e5d26a0f9107d3

ABSTRACT available

24. URBANUS AT, van de Laar TJ, van den Hoek A, Zuure FR, et al.

Hepatitis C in the general population of various ethnic origins living in the

Netherlands: should non-Western migrants be screened?

J Hepatol. 2011.

http://amedeo.com/p2.php?id=21703202 & s=hep & pm=3e5d26a0f9107d3

ABSTRACT available

25. TILLMANN HL, Patel K, Muir AJ, Guy CD, et al.

Beneficial IL28B genotype associated with lower frequency of hepatic steatosis

in

patients with chronic hepatitis C.

J Hepatol. 2011.

http://amedeo.com/p2.php?id=21703198 & s=hep & pm=3e5d26a0f9107d3

ABSTRACT available

26. DELTENRE P, Louvet A, Lemoine M, Mourad A, et al.

Impact of insulin resistance on sustained response in HCV patients treated with

pegylated interferon and ribavirin: a meta-analysis.

J Hepatol. 2011.

http://amedeo.com/p2.php?id=21703195 & s=hep & pm=3e5d26a0f9107d3

ABSTRACT available 20. BASSENDINE MF, Sheridan DA, Felmlee DJ, Bridge SH, et al.

HCV and the hepatic lipid pathway as a potential treatment target.

J Hepatol. 2011.

http://amedeo.com/p2.php?id=21718665 & s=hep & pm=3e5d26a0f9107d3

21. HEZODE C.

Oral combination therapy: Future hepatitis C virus treatment?

J Hepatol. 2011.

http://amedeo.com/p2.php?id=21708200 & s=hep & pm=3e5d26a0f9107d3

ABSTRACT available

18. SHIMADA M, Yoshida S, Masuzaki R, Schuppan D, et al.

Pitavastatin enhances antiviral efficacy of standard pegylated interferon plus

ribavirin in patients with chronic hepatitis C: A prospective randomized pilot

study.

J Hepatol. 2011.

http://amedeo.com/p2.php?id=21718671 & s=hep & pm=3e5d26a0f9107d3 9. HOEFS JC,

Shiffman ML, Goodman ZD, Kleiner DE, et al.

Rate of Progression of Hepatic Fibrosis in Patients with Chronic Hepatitis C:

Results from the HALT-C Trial.

Gastroenterology. 2011.

http://amedeo.com/p2.php?id=21699796 & s=hep & pm=3e5d26a0f9107d3

ABSTRACT available

10. GOTTWEIN JM, Scheel TK, Jensen TB, Ghanem L, et al.

Differential Efficacy of Protease Inhibitors against HCV Genotype 2a, 3a, 5a,

and

6a NS3/4A Protease Recombinant Viruses.

Gastroenterology. 2011.

http://amedeo.com/p2.php?id=21699793 & s=hep & pm=3e5d26a0f9107d3

ABSTRACT available

11. FOSTER GR, Hezode C, Bronowicki JP, Carosi G, et al.

Telaprevir Alone or with Peginterferon and Ribavirin Reduces HCV RNA in Patients

with Chronic Genotype 2 but Not 3 Infections.

Gastroenterology. 2011.

http://amedeo.com/p2.php?id=21699786 & s=hep & pm=3e5d26a0f9107d3

ABSTRACT available

12. MARABITA F, Aghemo A, De Nicola S, Rumi MG, et al.

Genetic variation in IL28B gene is not associated with fibrosis progression in

patients with chronic hepatitis C and known date of infection.

Hepatology. 2011 Jun 30. doi: 10.1002/hep.24503.

http://amedeo.com/p2.php?id=21721028 & s=hep & pm=3e5d26a0f9107d3

ABSTRACT available

6. SHIN EC, Park SH, Demino M, Nascimbeni M, et al.

Delayed Induction, Not Impaired Recruitment of Specific CD8(+) T Cells, Causes

the Late Onset of Acute Hepatitis C.

Gastroenterology. 2011.

http://amedeo.com/p2.php?id=21699897 & s=hep & pm=3e5d26a0f9107d3

ABSTRACT available

7. LONG G, Hiet MS, Windisch MP, Lee JY, et al.

Mouse hepatic cells support assembly of infectious hepatitis C virus particles.

Gastroenterology. 2011.

http://amedeo.com/p2.php?id=21699799 & s=hep & pm=3e5d26a0f9107d3

ABSTRACT available

8. HABERSETZER F, Honnet G, Bain C, Maynard-Muet M, et al.

A Poxvirus Vaccine Is Safe, Induces T-Cell Responses, and Decreases Viral Load

in

Patients With Chronic Hepatitis C.

Gastroenterology. 2011.

http://amedeo.com/p2.php?id=21699798 & s=hep & pm=3e5d26a0f9107d3

ABSTRACT available

2. SOLOMON M, Bonafede M, Pan K, K, et al.

Direct Medical Care Costs Among Pegylated Interferon Plus Ribavirin-Treated and

Untreated Chronic Hepatitis C Patients.

Dig Dis Sci. 2011.

http://amedeo.com/p2.php?id=21717127 & s=hep & pm=3e5d26a0f9107d3

ABSTRACT available

3. TOHRA SK, Taneja S, Ghosh S, Sharma BK, et al.

Prediction of Sustained Virological Response to Combination Therapy with

Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic

Hepatitis C.

Dig Dis Sci. 2011.

http://amedeo.com/p2.php?id=21706207 & s=hep & pm=3e5d26a0f9107d3

ABSTRACT available